Financial Data and Key Metrics Changes - The company reported a strong fiscal year 2025, with EPS and adjusted operating income both up 16% [5] - The stock price increased by approximately 55% over the year [5] - Long-term operating income guidance was raised to 6%-9% growth, with a 2026 forecast for U.S. healthcare operating income growth of 9%-11% [6][7] Business Line Data and Key Metrics Changes - The U.S. operating income growth is expected to be 9%-11%, with a potential 10%-12% growth when excluding a 1% headwind from a competitor acquisition [7][8] - The company is focusing on expanding its specialty business, particularly in oncology and retina markets, which are seen as key growth drivers [8][15] Market Data and Key Metrics Changes - The international healthcare solutions segment faced challenges, contributing only 15% to overall operating income, while the U.S. segment accounted for 85% [49] - The 3PL market is identified as the fastest-growing part of the international distribution business, with improvements noted in the global specialty logistics business [50][52] Company Strategy and Development Direction - The company is committed to a pharmaceutical-centric approach, focusing on specialty products and management services for physician practices [8][15] - Strategic acquisitions, particularly in the MSO space, are a priority, with plans to acquire the remaining 65% of OneOncology [17][63] - The company is also investing in infrastructure and technology, with capital expenditures projected at about $900 million [62][63] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term growth driven by pharmaceutical innovation and demographic trends [9] - There are concerns about potential policy-induced headwinds affecting coverage and insurance enrollment, but management believes pharmaceuticals remain a critical and efficient form of care [10][12] Other Important Information - The company is evaluating strategic alternatives for underperforming segments, including parts of PharmaLex, while retaining growth-oriented businesses [56][60] - The dividend growth rate was increased to 9%, aligning with long-term EPS growth guidance of 9%-13% [63] Q&A Session Summary Question: What are the key growth drivers for the MSO business? - The MSO business is seen as a natural evolution of the specialty business, providing additional management services to physician practices [14][15] Question: How does the company differentiate itself from competitors in the MSO space? - The company maintains a pharmaceutical-centric focus, which is a key differentiator in its strategy [15] Question: What impact do potential drug pricing changes have on the business? - Management emphasized the importance of community-based providers and the efficiency of pharmaceuticals in maintaining care access [25][26] Question: How is the company addressing challenges in the international market? - The company is focusing on the 3PL market and has seen improvements in its global specialty logistics business [50][52] Question: What is the company's approach to capital deployment? - The company prioritizes balanced capital deployment, including investments in business growth, strategic acquisitions, share repurchases, and dividend payments [62][63]

Group 1: Thanksgiving Closures - Most federal and financial institutions will pause operations on Thanksgiving Day, including banks, post offices, and the stock market (NYSE and Nasdaq) [2] - Major shipping carriers such as United Parcel Service Inc. and FedEx Corp. will suspend standard pickup and delivery services on this day [2] - Retail giants like Walmart Inc., Target Corp., Costco Wholesale Corp., Macy's Inc., and Kohl's Corp. will remain closed on Thanksgiving Day [3] Group 2: Thanksgiving Openings - Many grocery chains, including Kroger Co., Whole Foods, and Sprouts Farmers Market Inc., will be open on Thanksgiving, albeit with reduced hours [4] - Select pharmacies like CVS Health Corp. and Walgreens will operate, but customers should check local store hours as pharmacy counters may be closed [4] Group 3: Black Friday Operations - Business operations will resume on Black Friday, November 28, with banks and post offices reopening for regular service [6] - The stock market will open but will close early at 1 p.m. ET on Black Friday [6] - Major retailers, including Walmart and Target, will open at 6 a.m. for Black Friday deals, marking the start of the shopping season [6]

Market Performance & Trends - The Dow Jones Industrial Average reached a record high, up 12% or 600 points to 4792 [7] - The S&P 500 saw 343 names gaining, with only the tech sector (down 075%) in the red [8] - Healthcare led gains in the S&P 500, up over 2%, with energy and consumer staples also gaining at least 12% [9] - The Nasdaq Composite was under pressure due to Nvidia's drop [4][6] Company Specific News - Paramount Skydance's stock rose nearly 10% after raising its target for job cuts and cost-saving measures, aiming for at least $3 billion in cost savings and planning to invest $15 billion in Paramount Plus by 2026 [10][11] - RealReal's stock surged 38% after reporting EPS and sales above estimates and boosting its revenue guidance for the full year, with about 25% of the float being shorted [12] - Instacart's (Maplebear's) stock was up 5% after posting better-than-expected order growth and providing an upbeat earnings outlook [13] - Nvidia's shares fell 3% after SoftBank sold its entire stake for $583 billion to bankroll AI investments [14][15] - CoreWeave's shares dropped 163% after lowering its annual revenue forecast to $505 billion - $515 billion from a previous high of $535 billion due to a delayed customer contract [15][17] - Beyond Meat's fourth-quarter net revenue forecast missed the average analyst estimate, projecting $60 million - $65 million versus the Bloomberg consensus of $701 million [17] Economic & Policy Impacts - Potential government reopening by Friday could lead to a stream of data being released [4] - Airline cancellations were tracking around 1700, below the 2000-3000 seen in previous days [6] - Visa and MasterCard settled a 20-year litigation with retailers, potentially allowing retailers to reject certain premium cards with higher transaction costs [22][23][25] Labor Market & Corporate Policy - Walgreens is cutting pay for hourly workers and reducing paid vacation time for some holidays [18]

Walgreens will no longer give many of its retail workers paid vacation time for Thanksgiving, Christmas and other major holidays, as the company looks to cut costs under new owners. https://t.co/Px8E6NiJJD ...

Core Insights - Well-managed real estate investment trusts (REITs) can provide excellent dividend opportunities, with Realty Income, LTC Properties, and AGNC Investment being highlighted for their monthly payouts [1][2] - The real estate sector has shown resilience against interest rate hikes and is positioned to benefit from future cuts [3] Group 1: Realty Income (O) - Realty Income is recognized as a top choice for monthly dividends, boasting a long history of increasing payouts and stable earnings [4] - Major tenants include Dollar General, Walgreens, and Dollar Tree, which are considered recession-resistant and reliable in payment [5] - The current dividend yield for Realty Income is 5.51%, and the stock is viewed as undervalued below $60, especially compared to its previous trading levels above $75 in 2022 [6] Group 2: LTC Properties (LTC) - LTC Properties focuses on senior housing and healthcare facilities, which are expected to be lucrative due to a growing elderly population [7] - The U.S. population aged 80 and above is projected to increase by over 4 million between 2025 and 2030, leading to a total of 18.8 million [8] - There is a significant shortfall in senior housing, with a need for 560,000 new units by 2030, while only 191,000 units are expected to be added, resulting in a gap of nearly 370,000 units [8]

Core Viewpoint - Well-run real estate investment trusts (REITs) can provide reliable monthly dividends, making them attractive for investors seeking consistent income [3][4]. Summary by Category Monthly Dividend REITs - Realty Income (NYSE: O), LTC Properties (NYSE: LTC), and AGNC Investment (NASDAQ: AGNC) are highlighted as top monthly dividend REITs, offering 12 dividend payments a year [3][4]. - Realty Income is known for its long history of increasing dividend payouts and stable earnings, with a current dividend yield of 5.51% [6][8]. - LTC Properties focuses on senior housing and healthcare facilities, with a dividend yield of 6.52%, capitalizing on the growing elderly population [9][11]. - AGNC Investment provides capital to the U.S. housing market through agency residential mortgage-backed securities, offering a high dividend yield of 14.17% [12][13]. Market Conditions and Outlook - The real estate sector has shown resilience against record interest rate hikes and is expected to benefit from ongoing cuts [5]. - The demand for senior housing is projected to outpace supply significantly, with a shortfall of nearly 370,000 units expected by 2030 [10]. - AGNC's outlook remains positive due to favorable mortgage spreads and anticipated interest rate cuts, which could enhance its yield attractiveness [14].

Core Insights - CVS Health Corp is a leading player in the healthcare sector, competing with major companies like Walgreens and UnitedHealth Group [1] - RBC Capital upgraded CVS to an "Outperform" rating and raised the price target from $81 to $93 [1][5] Financial Performance - CVS reported third-quarter sales of $102.87 billion, exceeding the consensus estimate of $98.84 billion, representing a 7.8% year-over-year increase [2][5] - The company achieved adjusted earnings per share of $1.60, outperforming the analyst estimate of $1.37, despite a GAAP diluted loss per share of $3.13 due to a $5.7 billion goodwill impairment charge [3][5] - Adjusted operating income increased by 35.8% to $3.46 billion, primarily driven by growth in the Health Care Benefits segment [3] Market Activity - CVS's stock price is currently at $76.81, reflecting a decrease of 4.70% or $3.79, with a trading volume of 6,168,140 shares on the NYSE [4] - Over the past year, CVS's stock reached a high of $85.15 and a low of $43.56 [4] Strategic Initiatives - CVS is preparing to collaborate with EMD Serono on the TrumpRx Fertility Program, set to launch in 2026 [4]

Core Viewpoint - CVS Health Corporation is highlighted as a strong investment opportunity, particularly in the context of the retail pharmacy sector, following the struggles of competitors like Rite Aid and Walgreens [1] Company Overview - CVS Health Corporation operates in health services, including insurance, pharmacy benefit management, and retail pharmacy operations [1] - The stock has seen significant performance, being noted as the best performer in the healthcare sector within the S&P, with an increase of over 58% for the year [1] Market Position - CVS is described as the "last man standing" in the retail pharmacy space, which has contributed to its strong stock performance [1] - The stock's previous decline has set a favorable stage for its current recovery and growth [1] Investment Considerations - While CVS is recognized for its potential, there are suggestions that certain AI stocks may offer greater upside potential with less downside risk [1]

Company Overview - Agree Realty is a retail net lease REIT with an enterprise value of $12.2 billion[9] - The company owns 2,603 retail properties totaling approximately 53.7 million square feet across all 50 states[9] - The company has investment grade issuer ratings of A- from Fitch, Baa1 from Moody's, and BBB+ from S&P[9] Financial Highlights - The company raised 2025 AFFO per share guidance to $4.31 to $4.33, representing 4.4% growth at the midpoint[12] - The company has total liquidity of over $1.9 billion[12] - The company invested $451 million during Q3 2025 across 110 high-quality retail net lease assets spanning 34 states[14] - Approximately 70% of base rents acquired in Q3 2025 derived from investment grade retailers[14] Portfolio Composition - The company's top tenant sector is grocery stores, accounting for 10.3% of total annualized base rent (ABR) at $72.9 million[56] - Home Improvement sector accounts for 8.8% of total ABR at $62.5 million[56] - Convenience Stores account for 7.8% of total ABR at $54.9 million[56]

Core Insights - InnerScope Hearing Technologies Inc. plays a pivotal role in the acquisition of OTCHealth Inc. by Ainnova Tech Inc., marking a significant milestone for the company in leveraging its retail distribution agreements and technology pipeline for growth in healthcare markets [1][2][3] Company Strategy and Operations - InnerScope will transition the majority of its sales operations, including retail agreements with major U.S. retailers like Walmart, CVS, and Walgreens, to OTCHealth, allowing OTCHealth to maximize these partnerships [2][4] - The company aims to focus on advancing its proprietary hearing technologies and integrating these innovations into OTCHealth's offerings, enhancing the overall value proposition [5][6] Market and Industry Context - The partnership recognizes that hearing loss affects 1.5 billion people globally and is linked to chronic diseases, emphasizing the need for integrated healthcare solutions [6] - Ainnova Tech's AI-driven diagnostics platform will complement InnerScope's hearing technology, creating a comprehensive healthcare ecosystem for early disease detection [3][6] Shareholder Benefits - InnerScope will receive equity and profit participation in both OTCHealth and Ainnova Tech post-acquisition, positioning shareholders to benefit from anticipated growth and expanded market reach [4][8]